4/A

FORM 4/A SUBMISSION

Company: KalVista Pharmaceuticals, Inc.
Filed: May 22, 2023
Period of Report: February 17, 2023
Accession Number: 0001209191-23-031631

View Document ↗ View on SEC.gov ↗